RONC3 – Treatment for HPV-mediated cervical cancer

RONC3 is Redbiotec’s oncology program based on the BRISPR platform technology.

It is currently being evaluated against HPV-mediated cervical cancer and other tumors.

Patent status: pending

Learn more about Redbiotec’s unique technology platform – BRISPR